Skip to main content
See every side of every news story
Published loading...Updated

Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start

The state says the biosimilar is available with or without insurance and costs far less than brand-name insulin.

Summary by KFF Health News
SAN FRANCISCO — At a Walgreens in this city’s bustling Japantown neighborhood, pharmacist Margaret On stocks two boxes of long-acting insulin pens from California’s new prescription drug label, CalRx, emblazoned with the state’s iconic grizzly bear. Although she hasn’t dispensed any, On plans to keep them on hand. “It’s good to have if a patient comes in and doesn’t have health insurance,” she said. “Or just in case of emergencies.” Seven months…

5 Articles

Lean Right

California sells US$55 insulin with its state brand CalRx, an alternative for patients with diabetes that many still don't know; know who can access

·Vicente López, Argentina
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

KFF Health News broke the news in San Francisco, United States on Monday, August 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal